Euronext N.V. (EPA:ENX)
France
· Delayed Price · Currency is EUR 146.00
-0.10 (-0.07%)
Jun 27, 2025, 5:17 PM CET
Euronext Revenue
Euronext had revenue of 458.40M EUR in the quarter ending March 31, 2025, with 14.06% growth. This brings the company's revenue in the last twelve months to 1.68B, up 11.91% year-over-year. In the year 2024, Euronext had annual revenue of 1.63B with 10.32% growth.
Revenue (ttm)
1.68B
Revenue Growth
+11.91%
P/S Ratio
8.92
Revenue / Employee
692.48K
Employees
2,455
Market Cap
15.01B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.63B | 152.21M | 10.32% |
| Dec 31, 2023 | 1.47B | 55.90M | 3.94% |
| Dec 31, 2022 | 1.42B | 120.16M | 9.25% |
| Dec 31, 2021 | 1.30B | 414.34M | 46.85% |
| Dec 31, 2020 | 884.32M | 205.21M | 30.22% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AXA SA | 91.26B |
| BNP Paribas | 46.14B |
| Crédit Agricole | 35.27B |
| Société Générale Société anonyme | 25.75B |
| Amundi | 6.74B |
| Edenred SE | 2.61B |
| Compagnie du Cambodge | 31.30M |
| SCOR SE | 16.34B |
Euronext News
- 10 days ago - Virtualware will uplist on Euronext Growth Paris on June 19, following market approval - GlobeNewsWire
- 13 days ago - Cegedim : Implementation of the plan to transfer the listing of the Group's shares on Euronext Growth - GlobeNewsWire
- 15 days ago - TOUAX SCA's Combined General Meeting of Shareholders approves the proposed transfer of listing from Euronext Paris to Euronext Growth Paris - GlobeNewsWire
- 16 days ago - argenx Presents New Efgartigimod Data at EULAR 2025 Highlighting Positive Phase 2 Proof-of-Concept Results in Myositis and Sjogren's Disease - Benzinga
- 17 days ago - Euronext announces volumes for May 2025 - GlobeNewsWire
- 18 days ago - Global companies revisiting plans to list in U.S. under Trump, says Euronext CEO - CNBC
- 23 days ago - 74Software joins Euronext Tech Leaders, the initiative for high-growth and leading Tech companies - GlobeNewsWire
- 23 days ago - Sidetrade joins the Euronext Tech Leaders 2025 - GlobeNewsWire